glp-1 obesity drugs drug cuts opiate craving | Science Market Overview: GLP-1 Agonists and
Description
Quantification of the contribution of GLP-1 to mediating insulinotropic effects of DPP-4 inhibition with vildagliptin in healthy subjects and patients with type 2 diabetes using exendin [939] as a GLP-1 receptor antagonist
Notice something
53.Cefalu WT, Kaul S, Gerstein HC, et al
Trends Endocrinol Metab 2022;33:42442.ArticlePubMed 78
Optic neuropathy: Theres damage to the optic nerve, which is crucial for communication between the eyes and the brain
Cell Metab 27(4):740756 Holst JJ (2019) From the incretin concept and the discovery of GLP-1 to todays diabetes therapy
